Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation

Int Immunopharmacol. 2021 Aug:97:107819. doi: 10.1016/j.intimp.2021.107819. Epub 2021 Jun 4.

Abstract

Tanshinones, the active ingredients derived from the roots of Salvia miltiorrhiza, have been widely used as traditional medicinal herbs for treating human diseases. Although tanshinones showed anti-inflammatory effects in many studies, large knowledge gaps remain regarding their underlying mechanisms. Here, we identified 15 tanshinones that suppressed the activation of NLRP3 inflammasome and studied their structure-activity relationships. Three tanshinones (tanshinone IIA, isocryptotanshinone, and dihydrotanshinone I) reduced mitochondrial reactive-oxygen species production in lipopolysaccharide (LPS)/nigericin-stimulated macrophages and correlated with altered mitochondrial membrane potentials, mitochondria complexes activities, and adenosine triphosphate and protonated-nicotinamide adenine dinucleotide production. The tanshinones may confer mitochondrial protection by promoting autophagy and the AMP-activated protein kinase pathway. Importantly, our findings demonstrate that dihydrotanshinone I improved the survival of mice with LPS shock and ameliorated inflammatory responses in septic and gouty animals. Our results suggest a potential pharmacological mechanism whereby tanshinones can effectively treat inflammatory diseases, such as septic and gouty inflammation.

Keywords: Dihydrotanshinone I; Gout; Mitochondrial reactive-oxygen species; NLRP3 inflammasome; Septic shock; Tanshinone.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Abietanes / pharmacology*
  • Abietanes / therapeutic use
  • Animals
  • Autophagy / drug effects
  • Autophagy / immunology
  • Disease Models, Animal
  • Female
  • Furans / pharmacology*
  • Furans / therapeutic use
  • Gout / chemically induced
  • Gout / drug therapy*
  • Gout / immunology
  • Gout / pathology
  • Humans
  • Inflammasomes / antagonists & inhibitors*
  • Inflammasomes / metabolism
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / pathology
  • Male
  • Mice
  • Mitochondria / drug effects
  • Mitochondria / pathology
  • NLR Family, Pyrin Domain-Containing 3 Protein / antagonists & inhibitors
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Phenanthrenes / pharmacology*
  • Phenanthrenes / therapeutic use
  • Quinones / pharmacology*
  • Quinones / therapeutic use
  • Rats
  • Reactive Oxygen Species / metabolism
  • Shock, Septic / drug therapy*
  • Shock, Septic / immunology
  • Shock, Septic / pathology
  • Uric Acid / administration & dosage
  • Uric Acid / toxicity

Substances

  • Abietanes
  • Furans
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Nlrp3 protein, rat
  • Phenanthrenes
  • Quinones
  • Reactive Oxygen Species
  • tanshinone
  • Uric Acid
  • dihydrotanshinone I
  • AMP-Activated Protein Kinases